|drug3331||T3 solution for injection Wiki||0.71|
|drug2083||Monitoring Visit - Baseline Wiki||0.71|
|drug1529||Hydroxychloroquine - Daily Dosing Wiki||0.71|
|drug3714||Weekly Assessment Wiki||0.71|
|drug2084||Monitoring Visit - Week 4 Wiki||0.71|
|drug2085||Monitoring Visit - Week 8 Wiki||0.71|
|drug1531||Hydroxychloroquine - Weekly Dosing Wiki||0.50|
|drug2557||Placebo oral tablet Wiki||0.13|
|D003141||Communicable Diseases NIH||0.05|
|D045169||Severe Acute Respiratory Syndrome NIH||0.03|
There are 2 clinical trials
Study times to evaluate the efficacy of N-Acetylcysteine therapy in the management of adult admitted patients with COVID-19.
Description: Day of recovery is defined as the first day on which of the following three categories from The Ordinal Scale on Covid-19 Clinical Improvement Not-Hospitalized, No limitation on activity. Not Hospitalized, with limitation on activity. Hospitalized, Not requiring supplemental OxygenMeasure: Time to Recovery Time: 28 days
The purpose of this trial is to assess the safety and toxicity profile of the combination of famotidine and oral n-acetyl cysteine in adult outpatients with newly diagnosed SARS-CoV-2 infection.
Description: Data will be collected and entered into Case Report Form in local REDCap sever to include MedDRA Code, Grade and all other data required by NIH per Memorandum, "Guidance for Collection of Adverse Events Related to COVID-19 Infection" dated on 25 March 2020. All data will be reported per this memorandum and in accordance with all applicable Institutional Review Board and FDA requirements.Measure: Number of participants with treatment-related adverse events as assessed by CTCAE v5.0 Time: 0 to 3 months
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports